These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6311043)

  • 41. [Epidemiological study of hepatitis A using the measurement of anti-VHA antibody].
    Grau A; Bertomeu F; Luna J; Llorente A; Vich JM; Anguiz A; Albero J; Bofill D; Simo E
    Rev Clin Esp; 1982 Apr; 165(1):11-3. PubMed ID: 6289388
    [No Abstract]   [Full Text] [Related]  

  • 42. Viral hepatitis in South African healthcare workers at increased risk of occupational exposure to blood-borne viruses.
    Vardas E; Ross MH; Sharp G; McAnerney J; Sim J
    J Hosp Infect; 2002 Jan; 50(1):6-12. PubMed ID: 11825045
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Viral hepatitis among prisoners in Norway.
    Hurlen B; Siebke JC; Stensland A
    NIPH Ann; 1980 Dec; 3(2):129-32. PubMed ID: 7219839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Viral markers of acute hepatitis: a study in 291 children and adults in Chile].
    Velasco M; Puelma E; Katz R; Zacarías J
    Rev Med Chil; 1982 Jun; 110(6):542-6. PubMed ID: 6819623
    [No Abstract]   [Full Text] [Related]  

  • 45. [Immunological markers of viral hepatitis in commercial series of immunoglobulin].
    Burlev VA; Gerasun BA
    Vrach Delo; 1983 Nov; (11):112-4. PubMed ID: 6318446
    [No Abstract]   [Full Text] [Related]  

  • 46. The role of hepatitis virus A and B in jaundice in south Ethiopia.
    Henriksen TH
    Ethiop Med J; 1984 Jan; 22(1):39-43. PubMed ID: 6690302
    [No Abstract]   [Full Text] [Related]  

  • 47. [Role of A virus in the genesis of chronic hepatitis and distribution of its antibodies in the current adult Spanish population].
    Jiménez-Saenz M; Herrerias JM; Pérez-Cano R; Pineda A; Garrido M
    Rev Clin Esp; 1981 Sep; 162(6):269-70. PubMed ID: 6276937
    [No Abstract]   [Full Text] [Related]  

  • 48. [Multiannual incidence of the HBs system in different categories of subjects].
    Jebeleanu L; Molnar GB; Mureşan L; Răcăşan R; Ionescu N; Dimoftache E; Bardos M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1982; 27(2):91-6. PubMed ID: 7146762
    [No Abstract]   [Full Text] [Related]  

  • 49. [Hepatitis B: serological strategy and epidemiological aspects].
    Penna R; Rabagliati AM
    G Batteriol Virol Immunol; 1981; 74(1-6):145-62. PubMed ID: 7030851
    [No Abstract]   [Full Text] [Related]  

  • 50. Serological markers for hepatitis types A and B among United States Army blood donors.
    James JJ; Heath DG; Cowan DN; Polk AJ; Johnson WL; Stienmier RH
    Mil Med; 1981 Aug; 146(8):562-7. PubMed ID: 6793898
    [No Abstract]   [Full Text] [Related]  

  • 51. Viral hepatitis in homosexual men.
    Fawaz KA; Matloff DS
    Gastroenterology; 1981 Sep; 81(3):537-8. PubMed ID: 7250641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Serologic markers for hepatitis B virus in a group of healthy individuals (author's transl)].
    Vargas V; Pedreira JD; Esteban R; Hernández JM; Piqueras J; Guardia J
    Med Clin (Barc); 1982 Apr; 78(7):265-7. PubMed ID: 7087592
    [No Abstract]   [Full Text] [Related]  

  • 53. [Is there a higher risk of illness in health and care personnel as compared to the population? A contribution to the epidemiology of virus hepatitis].
    Ruof H
    Arch Hyg Bakteriol; 1968 Apr; 152(2):170-80. PubMed ID: 5707379
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hepatitis b seroprevalence in hospital personnel].
    Leblebicioğlu H; Günaydin M; Durupinar B
    Mikrobiyol Bul; 1993 Apr; 27(2):113-8. PubMed ID: 8502182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis among hospital employees.
    Palmer DL; Barash M; King R; Neil F
    West J Med; 1983 Apr; 138(4):519-23. PubMed ID: 6868575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prevalence of antibodies to hepatitis A, hepatitis B and hepatitis C viruses in the German population].
    Thierfelder W; Meisel H; Schreier E; Dortschy R
    Gesundheitswesen; 1999 Dec; 61 Spec No():S110-4. PubMed ID: 10726407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prophylactic effectiveness of immunoglobulin preparations with different amounts of specific antibodies to the hepatitis A virus].
    Perepelkin VS; Sumarokov AA; Gorbunov MA; Tiantov GA; Borzykh VA
    Voen Med Zh; 1988 Dec; (12):37-9. PubMed ID: 2853893
    [No Abstract]   [Full Text] [Related]  

  • 58. [Serum immunoglobulin level of viral hepatitis patients at different stages of the disease].
    Nagornova TF; Marichev IL; Raksha EA; Markov IS
    Vrach Delo; 1983 Nov; (11):115-6. PubMed ID: 6318447
    [No Abstract]   [Full Text] [Related]  

  • 59. [Prevalence of surface antigens (HBsAg), surface antibody (HBsAb) and anticore antibody (HBcAb) in hospital personnel and patients with and without hepatic pathology].
    Ardito D; Bianco T; Demundo T; Loiodice L
    Minerva Med; 1980 Oct; 71(39):2815-20. PubMed ID: 7432690
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Viral hepatitis A: specific immunologic aspects before and after exposure to risk].
    Laverdant C; Hainaut J; Dutertre J
    Bull Acad Natl Med; 1983 Jun; 167(6):619-26. PubMed ID: 6318924
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.